The research summarized in this whitepaper provides a number of examples of how ALZET® pumps offer a superior pre-clinical drug dosing option for the delivery of a wide array of anti-cancer agents, including small molecules, immunotherapies, radiotherapies, combination treatments, and novel drug entities.

This whitepaper also explores how ALZET® pumps have been used to successfully test treatments for cancer-associated syndromes and treatment-related side effects.

Download Whitepaper